By expenditures
| Name | Title | Type |
|---|---|---|
| Anna Davis | Cfo | Auditee |
| Rebecca Robins | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 389349 | 2025 | 2026-02-26 | FORVIS MAZARS LLP | $46.00M |
| 333362 | 2024 | 2024-12-18 | Forvis Mazars LLP | $45.31M |
| 10953 | 2023 | 2024-01-11 | Forvis LLP | $45.33M |
| 31365 | 2022 | 2023-03-05 | Forvis LLP | $48.39M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 31365 | 2022 | 2023-03-05 | 606995 | 2022-002 | Significant Deficiency | - | L |
| 31365 | 2022 | 2023-03-05 | 606994 | 2022-003 | Significant Deficiency | - | I |
| 31365 | 2022 | 2023-03-05 | 606993 | 2022-002 | Significant Deficiency | Yes | L |
| 31365 | 2022 | 2023-03-05 | 606992 | 2022-001 | Significant Deficiency | - | N |
| 31365 | 2022 | 2023-03-05 | 30553 | 2022-002 | Significant Deficiency | - | L |
| 31365 | 2022 | 2023-03-05 | 30552 | 2022-003 | Significant Deficiency | - | I |
| 31365 | 2022 | 2023-03-05 | 30551 | 2022-002 | Significant Deficiency | Yes | L |
| 31365 | 2022 | 2023-03-05 | 30550 | 2022-001 | Significant Deficiency | - | N |